台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    65.0
  • 漲跌
    ▼2.3
  • 漲幅
    -3.42%
  • 成交量
    434
  • 產業
    上櫃 生技醫療類股
  • 73人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-凱基-宜蘭 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2803/1203/2404/0604/1604/2805/0805/10405060708090Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

凱基-宜蘭 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/3000.003060.2859.60-30470-6.37%
2025/04/243056.5000.0056.50304676.42%
2025/04/0200.00166.1066.60-1505-0.20%
2025/03/2000.00173.1073.10-1595-0.17%
2025/03/19175.80273.8072.60-1598-0.17%
2025/03/18178.00175.5075.5006020.00%
2025/03/17177.70177.5077.5006160.00%
2025/03/14279.80177.7077.7016170.16%
2025/03/13176.90180.3081.0006030.00%
2025/03/12182.007680.3577.50-75585-12.80%
2025/03/117680.6200.0081.507655713.62%
2025/03/0500.00168.9068.90-1484-0.21%
2025/03/0400.003068.8269.60-30483-6.20%
2025/03/032968.7600.0069.60294836.00%
2025/02/26167.0000.0066.4014900.20%
2025/02/2000.00170.9071.00-1497-0.20%
2025/02/18162.1000.0062.6015020.20%
2025/02/13161.9000.0062.8015740.17%
2025/01/06064.6000.0065.1006230.01%
2024/12/3100.005064.1964.30-50669-7.47%
2024/12/3050.265.7100.0066.7050.26927.24%
2024/12/260.272.6000.0066.600.26920.03%
2024/12/2400.001171.7173.00-11677-1.62%
2024/12/2000.004460.8060.40-44684-6.43%
2024/12/1944.463.652261.9062.7022.46953.22%
2024/12/1821.260.14158.7060.9020.26782.98%
2024/12/12154.90154.5054.9006780.00%
2024/12/11154.9000.0054.9016660.15%
2024/12/09362.0000.0062.0036460.46%
2024/12/04167.0000.0067.0016550.15%
2024/12/02166.6000.0066.6016630.15%
2024/11/28164.6000.0064.8016720.15%
2024/11/2500.005472.8271.90-54681-7.92%
2024/11/225472.1900.0073.00546728.03%
2024/11/1800.00167.0067.00-1676-0.15%
2024/11/13264.2000.0064.0026520.31%
2024/11/12263.1000.0070.0026320.32%
2024/11/11270.5000.0070.1026060.33%
2024/10/251100.5000.00100.0016870.15%
2024/10/221104.501106.00107.0007260.00%
2024/10/211102.5000.00105.5017360.14%
2024/10/181118.0000.00110.0017680.13%
2024/10/0700.003108.50116.50-3830-0.36%
2024/10/04291.0000.00106.5028130.25%
2024/10/01197.2000.0097.2017870.13%
2024/08/0700.001179.00180.00-1781-0.13%
2024/08/0600.007180.00171.00-7777-0.90%
2024/08/057176.2938174.95180.00-31768-4.03%
2024/08/0238177.9742173.71177.50-4749-0.53%
2024/08/0142172.6324168.17175.50187322.46%
2024/07/3124161.7900.00161.00247273.30%
2024/07/2200.0059167.53164.00-59667-8.85%
2024/07/1959179.6300.00182.00596509.06%
2024/06/07198.1000.0098.1013200.31%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音